In addition, donor Tc17 cells treated with LYC-53772 expressed less PD-1 in both spleen and tumor more than 2 weeks post-transfer, suggesting that the RORγ agonist exerted long-lasting effects on cytokine production and the expression of co-inhibitory receptors. The gene discussed is RORC; the disease is neoplasm.